Developing an Optimized Risk Assessment Portfolio-- The Quality Risk Management Master Plan.
| Publicado en: | Pharmaceutical Technology Europe Vol. 36; no. 1; pp. 23 - 28 |
|---|---|
| Autores principales: | , |
| Formato: | pictorial tables/charts Journal Article |
| Publicado: |
MJH Life Sciences
Jan2024
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=175175705&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 175175705 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 17537967 5NG jtl: Pharmaceutical Technology Europe issn: 17537967 maglogo: N pubinfo: dt: Jan2024 vid: 36 iid: 1 pid: 54670 pub: MJH Life Sciences place: Cranbury, New Jersey artinfo: ui: 175175705 175175705 175175705 175175705 ppf: 23 ppct: 5 formats: fmt: @attributes: type: P tig: atl: Developing an Optimized Risk Assessment Portfolio-- The Quality Risk Management Master Plan. aug: au: Waldron, Kelly Baker, Tiffany affil: Business unit manager, Quality and Manufacturing Science Consulting sug: subj: Pharmaceutical Companies Risk Assessment Risk Management Quality Improvement Quality Assessment Program Development Strategic Planning Manufacturing Industry Equipment Safety Decision Making, Organizational Technology, Pharmaceutical Patient Safety Equipment Contamination Prevention and Control Equipment Design pubtype: Trade Publication doctype: pictorial tables/charts Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|